Corbus Pharmaceuticals Holdings, Inc.
CRBP$68M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNORWOOD28 employees
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
3
Next Catalyst
Aug 4, 2026
6wMarket Overview
Stock performance and key metrics
CRBP News
Catalyst Timeline
3 upcoming, 0 past
Drug Pipeline
Lenabasum 5 mg
Dermatomyositis
Lenabasum 20 mg
Cystic Fibrosis
JBT-101 (lenabasum)
Cystic Fibrosis
CRB-601 monoclonal antibody
Solid Tumor
CRB-701
Solid Tumor, Adult
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Lenabasum 5 mg | Phase 3 | Dermatomyositis | - | - |
Lenabasum 20 mg | Phase 3 | Cystic Fibrosis | - | - |
JBT-101 (lenabasum) | Phase 2 | Cystic Fibrosis | - | - |
CRB-601 monoclonal antibody | Phase 2 | Solid Tumor | - | - |
CRB-701 | Phase 2 | Solid Tumor, Adult | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply